Anti-Cas9 immunity: A formidable challenge for muscle genome editing.
Molecular therapy : the journal of the American Society of Gene Therapy, 30(1): 10-12 PMID 34895501 DOI 10.1016/j.ymthe.2021.12.006
Abstract
This article has no abstract in PubMed.